Published • loading... • Updated
INVIMA Approves IntelliGenome’s CRISPR-TB Blood Test for Sale in Colombia
Summary by Finance Colombia
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
INVIMA Approves IntelliGenome’s CRISPR-TB Blood Test for Sale in Colombia
Colombia’s Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA, the National Institute for Food and Drug Surveillance) has granted sanitary registration to the CRISPR-TB Blood Test Kit, a molecular diagnostic for tuberculosis developed by IntelliGenome, clearing the test for commercial sale in the country. The registration, issued under INVIMA Registration No. 2026RD-0009793, authorizes the importation and sale of the assay in C…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
